mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.06 |